Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](SymBio Pharmaceuticals)"
Count: 24
Selected: 0
NCT IDTitle
NCT03005899Study of SyB P-1501 (Fentanyl HCI) for Treatment of Postoperative Pain
NCT05511779Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation
NCT04706923A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection (ATHENA)
NCT04542252Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects
NCT04354402Follow-up Study of SyB L-0501 in Combination With Rituximab to Treat DLBCL
NCT03900377Phase I/II Study of SyB L-0501RI in Combination With Rituximab to Treat Lymphoma
NCT03604679SyB C-0501(Oral Bendamustine) in Patients With Advanced Solid Tumors
NCT03495167Study of SyB C-1101 in Patients With Myelodysplastic Syndrome
NCT03372837Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell Lymphoma
NCT02783547Combination Therapy of SyB C-1101 and Azacytidine in Patients With Myelodysplastic Syndrome
NCT02042911Efficacy and Safety Study of SyB L-0501 for Patients With Chronic Lymphocytic Leukemia
NCT02014051Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)
NCT02002936Long Term Safety Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study
NCT02000154Long Term Safety Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study
NCT01849848Study of SyB L-0501 to Treat Relapsed/Refractory Multiple Myeloma
NCT01718691Efficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B Cell Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
NCT01700335Safety and Pharmacokinetics Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)
NCT01700140Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
NCT01179490Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma
NCT01118845Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT00794638A Phase I Clinical Trial of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-cell Non-Hodgkin's Lymphoma
NCT00612183Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma
NCT00389051A Phase I Study of Bendamustine Hydrochloride in Patients With Indolent B-cell Non-Hodgkin's Lymphoma
NCT01650051Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)